StockData
Scinai Immunotherapeutics Ltd. logo

Scinai Immunotherapeutics Ltd. (SCNI) stock

SCNINasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 1, 2026Score 6/30
$0.37−0.01 (-1.40%)

Close on Nov 18, 2026Market cap $1.27MP/E –Yield –

Scinai Immunotherapeutics cash

Cash and short-term investments held at the end of each period.

Scinai Immunotherapeutics's cash was $2.65M at Jun 30, 2026. For fiscal 2025 it was $1.66M, down 20.7% from the year before. The highest annual figure on record is $22.54M in fiscal 2019.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$1.66M-20.7%
FY2024Dec 31, 2024$2.10M-57.0%
FY2023Dec 31, 2023$4.87M-65.7%
FY2022Dec 31, 2022$14.22M-18.9%
FY2021Dec 31, 2021$17.52M+469.3%
FY2020Dec 31, 2020$3.08M-86.3%
FY2019Dec 31, 2019$22.54M+9.5%
FY2017Dec 31, 2017$20.59M+354.5%
FY2016Dec 31, 2016$4.53M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$2.65M-13.7%
Q4 FY2025Dec 31, 2025$1.66M-65.9%
Q2 FY2025Jun 30, 2025$989.00K-1.1%
Q4 FY2024Dec 31, 2024$2.10M-72.1%
Q2 FY2024Jun 30, 2024$3.08M-71.5%
Q4 FY2023Dec 31, 2023$4.87M-65.7%
Q3 FY2023Sep 19, 2023$1.00M-91.1%
Q2 FY2023Jun 30, 2023$7.51M-51.2%
Q1 FY2023Mar 31, 2023$10.80M-38.4%
Q4 FY2022Dec 31, 2022$14.22M+32.4%
Q2 FY2022Jun 30, 2022$11.29M+266.8%
Q1 FY2022Mar 31, 2022$15.39M-31.7%
Q4 FY2021Dec 31, 2021$17.52M-14.9%
Q3 FY2021Sep 30, 2021$10.74M+137.0%
Q4 FY2020Dec 31, 2020$3.08M–
Q4 FY2019Dec 31, 2019$22.54M–
Q4 FY2017Dec 31, 2017$20.59M–
Q4 FY2016Dec 31, 2016$4.53M–

More Scinai Immunotherapeutics figures

See a number that looks wrong?